oxazolidin-2-one has been researched along with thiazoles in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (38.10) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akasaka, K; Horie, T; Kagaya, T; Kubota, A; Nagato, S; Naitoh, T | 1 |
| Freund, P; Heitzmann, T; Neidlein, R; Reiff, K; Strein, K | 1 |
| Akasaka, K; Kagaya, T; Kajiwara, A; Kubota, A; Nagato, S | 1 |
| Horie, T; Kagei, Y; Kakiki, M; Kawaguchi, S; Naitoh, T | 1 |
| Andoh, T; Horie, T; Kagei, K; Kakiki, M; Kawaguchi, S; Matsui, K; Mishima, M; Naitoh, T; Yuzuriha, T | 1 |
| Horie, T; Kakiki, M; Kozaki, T; Mishima, M; Naitoh, T; Yuzuriha, T | 1 |
| Horie, T; Kajiwara, A; Kakiki, M; Kawaguchi, S; Naitoh, T; Ohe, H | 1 |
| Aoki, T; Chimoto, T; Hosokawa, S; Sagami, F; Sato, G; Sumigama, S; Tsukidate, K | 1 |
| Asakura, S; Hakura, A; Kobayashi, N; Sato, G; Tsukidate, K; Tsutsui-Hiyoshi, Y | 1 |
| Aoki, T; Hosokawa, S; Sagami, F; Sato, G; Tsukidate, K | 1 |
| Chaudhary, K; Crimmins, MT; King, BW; Tabet, EA | 1 |
| Ikeda, H; Kawada, M; Maekawa, T; Momose, Y; Odaka, H; Sohda, T; Yamano, T | 1 |
| Hawser, SP | 1 |
| Chidawanyika, T; de Carvalho, LP; Deng, H; Li, D; Li, H; Lin, G; Nathan, C; Schneider, J; Tao, H; Vogt, G; Warren, JD; Wu, K | 1 |
| Adibpour, N; Khalaj, A; Rajabalian, S | 1 |
| Newman, M | 1 |
| Leggio, M; Podos, SD; Pucci, MJ; Thanassi, JA | 1 |
| Berthelot, P; Boukhalfa, K; Caignard, DH; Delagrange, P; Ettaoussi, M; Landagaray, E; Rami, M; Yous, S | 1 |
| Ang, W; Chang, Y; Chen, G; Li, G; Liu, Y; Long, H; Luo, Y; Sang, Z; Tang, J; Wang, Z; Wei, Y; Yang, S; Yang, T; Yang, X; Zhang, J | 1 |
| Alam, MJ; Bassères, E; Dotson, KM; Endres, BT; Garey, KW | 1 |
| Hoegy, F; Mislin, GLA; Paulen, A; Roche, B; Schalk, IJ | 1 |
1 review(s) available for oxazolidin-2-one and thiazoles
| Article | Year |
|---|---|
Novel antibiotics in development to treat Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Benzimidazoles; Benzopyrans; Clinical Trials as Topic; Clostridium Infections; Depsipeptides; Humans; Lipopeptides; Oxazolidinones; Peptides, Cyclic; Pyridines; Thiazoles; Thiophenes | 2017 |
20 other study(ies) available for oxazolidin-2-one and thiazoles
| Article | Year |
|---|---|
Application of pharmacokinetic studies to a novel antidepressant, E2011.
Topics: Animals; Antidepressive Agents; Benzothiazoles; Biotransformation; Chromatography, High Pressure Liquid; Dogs; In Vitro Techniques; Male; Microsomes, Liver; Mixed Function Oxygenases; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles | 1994 |
Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice.
Topics: Animals; Benzofurans; Chromatography, High Pressure Liquid; Half-Life; Hypoglycemic Agents; Male; Mice; Mice, Inbred Strains; Naphthalenes; Oxazoles; Oxazolidinones; Spectrophotometry, Ultraviolet; Thiazoles; Thiazolidinediones | 1995 |
E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
Topics: Animals; Benzothiazoles; Brain; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; Oxazoles; Oxazolidinones; Rats; Rats, Wistar; Serotonin; Thiazoles | 1996 |
Stereoselective determination of a new antidepressant, E2011, and its diastereoisomer as a metabolite by high-performance liquid chromatography.
Topics: Animals; Antidepressive Agents; Benzothiazoles; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Male; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles | 1997 |
Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog.
Topics: Absorption; Animals; Benzothiazoles; Biliary Tract; Blood Proteins; Carbon Radioisotopes; Dogs; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Protein Binding; Rats; Rats, Sprague-Dawley; Thiazoles; Tissue Distribution | 1997 |
Identification of the metabolites of a new oxazolidinone MAO-A inhibitor in rat.
Topics: Animals; Benzothiazoles; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Hydroxylation; Magnetic Resonance Spectroscopy; Male; Methylation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Rats, Sprague-Dawley; Spectrometry, Mass, Fast Atom Bombardment; Thiazoles | 1997 |
Species differences and mechanism of the epimerization of a new MAO-A inhibitor.
Topics: Administration, Oral; Animals; Benzothiazoles; Dogs; Guinea Pigs; Haplorhini; Isomerism; Mice; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Rats; Species Specificity; Thiazoles | 1998 |
Toxicological response of rats to a novel monoamine oxidase type-A inhibitor, (5R)-3-[2-((1S)-3-cyano-1-hydroxypropyl)benzothiazol-6-yl]-5- methoxymethyl-2-oxazolidinone (E2011), orally administered for 13 weeks.
Topics: Administration, Oral; Animals; Benzothiazoles; Body Weight; Eating; Female; Glutathione S-Transferase pi; Glutathione Transferase; Harderian Gland; Hematologic Tests; Isoenzymes; Liver; Liver Neoplasms, Experimental; Male; Monoamine Oxidase Inhibitors; Organ Size; Oxazoles; Oxazolidinones; Precancerous Conditions; Rats; Rats, Sprague-Dawley; Salivation; Thiazoles | 1999 |
Assessment of potential mutagenic activities of a novel benzothiazole MAO-A inhibitor E2011 using Salmonella typhimurium YG1029.
Topics: Acetyltransferases; Animals; Benzothiazoles; Biotransformation; Carcinogens; Liver; Liver Neoplasms; Monoamine Oxidase Inhibitors; Mutagenicity Tests; Mutagens; Oxazolidinones; Precancerous Conditions; Rats; Salmonella typhimurium; Structure-Activity Relationship; Thiazoles | 2000 |
Protection from drug-induced hepatocellular changes by pretreatment with conjugating enzyme inhibitors in rats.
Topics: Acetyltransferases; Animals; Benzothiazoles; Enzyme Inhibitors; Female; Glucuronosyltransferase; Liver; Monoamine Oxidase Inhibitors; Nitrophenols; Oxazolidinones; Pentachlorophenol; Ranitidine; Rats; Rats, Sprague-Dawley; Sulfotransferases; Thiazoles | 2001 |
Asymmetric aldol additions: use of titanium tetrachloride and (-)-sparteine for the soft enolization of N-acyl oxazolidinones, oxazolidinethiones, and thiazolidinethiones.
Topics: Magnetic Resonance Spectroscopy; Oxazolidinones; Sparteine; Spectrophotometry, Infrared; Thiazoles; Titanium | 2001 |
Novel 5-substituted 2,4-thiazolidinedione and 2,4-oxazolidinedione derivatives as insulin sensitizers with antidiabetic activities.
Topics: Animals; Chromatography, High Pressure Liquid; COS Cells; Crystallography, X-Ray; Diabetes Mellitus; Hypoglycemic Agents; Insulin; Male; Mice; Models, Chemical; Models, Molecular; Oxazolidinones; Rats; Rats, Wistar; Temperature; Thiazoles; Thiazolidinediones | 2002 |
Antibacterial drug discovery and development--SRI's 11th Annual Summit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Drug Design; Humans; Incidence; Lipoglycopeptides; Methicillin Resistance; Minocycline; Molecular Structure; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Tigecycline | 2006 |
Inhibitors selective for mycobacterial versus human proteasomes.
Topics: Catalytic Domain; Humans; Hydrogen Bonding; Kinetics; Models, Molecular; Mycobacterium tuberculosis; Oxazolidinones; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Carbonylation; Protein Conformation; Protein Subunits; Substrate Specificity; Thiazoles; Threonine | 2009 |
Synthesis and antibacterial activity of isothiazolyl oxazolidinones and analogous 3(2H)-isothiazolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Oxazolidinones; Thiazoles | 2010 |
Bitter pills for drug companies.
Topics: Acetamides; Drug Approval; Drug Industry; Fraud; gamma-Aminobutyric Acid; Isoxazoles; Linezolid; Motivation; Off-Label Use; Oxazolidinones; Piperazines; Pregabalin; Sulfonamides; Thiazoles; United States | 2010 |
Bactericidal activity of ACH-702 against nondividing and biofilm Staphylococci.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Biofilms; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Oxazolidinones; Quinolines; Quinolones; Rifampin; Staphylococcus; Thiazoles; Vancomycin | 2012 |
Novel conformationally constrained analogues of agomelatine as new melatoninergic ligands.
Topics: Acetamides; Animals; CHO Cells; Cricetinae; Isoxazoles; Ligands; Oxazolidinones; Pyrrolidinones; Radioligand Assay; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Structure-Activity Relationship; Tetrazoles; Thiazoles | 2012 |
Discovery of a Teraryl Oxazolidinone Compound (S)-N-((3-(3-Fluoro-4-(4-(pyridin-2-yl)-1H-pyrazol-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide Phosphate as a Novel Antimicrobial Agent with Enhanced Safety Profile and Efficacies.
Topics: Acetamides; Animals; Anti-Infective Agents; Bacteria; Biological Availability; Drug Design; Ether-A-Go-Go Potassium Channels; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Models, Molecular; Oxazoles; Oxazolidinones; Potassium Channel Blockers; Staphylococcal Infections; Structure-Activity Relationship; Tetrazolium Salts; Thiazoles | 2015 |
Synthesis of conjugates between oxazolidinone antibiotics and a pyochelin analogue.
Topics: Anti-Bacterial Agents; Drug Design; Oxazolidinones; Phenols; Pseudomonas aeruginosa; Siderophores; Thiazoles | 2017 |